Zurich Cantonal Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.1M Buy
365,451
+136,809
+60% +$23.9M 0.15% 121
2025
Q4
$38.9M Buy
228,642
+197,072
+624% +$30.2M 0.08% 195
2025
Q3
$4.16M Sell
31,570
-46,351
-59% -$5.56M 0.01% 653
2025
Q2
$8.27M Sell
77,921
-121,283
-61% -$13.2M 0.02% 495
2025
Q1
$24.7M Buy
199,204
+172,626
+650% +$22.5M 0.07% 252
2024
Q4
$3.27M Buy
26,578
+14,679
+123% +$1.73M 0.01% 696
2024
Q3
$1.33M Buy
11,899
+1,729
+17% +$189K ﹤0.01% 980
2024
Q2
$1.09M Sell
10,170
-29,474
-74% -$3.24M ﹤0.01% 1033
2024
Q1
$4.77M Buy
39,644
+531
+1% +$65K 0.02% 559
2023
Q4
$4.81M Buy
39,113
+8,814
+29% +$1.1M 0.02% 546
2023
Q3
$3.92M Sell
30,299
-1,974
-6% -$263K 0.02% 566
2023
Q2
$4M Buy
32,273
+183
+0.6% +$24.6K 0.02% 556
2023
Q1
$4.7M Buy
32,090
+23,019
+254% +$3.4M 0.02% 507
2022
Q4
$1.45M Sell
9,071
-665
-7% -$97.5K 0.01% 755
2022
Q3
$1.3M Buy
9,736
+646
+7% +$98.2K 0.01% 777
2022
Q2
$1.42M Sell
9,090
-3,611
-28% -$556K 0.01% 753
2022
Q1
$1.98M Sell
12,701
-90,284
-88% -$13.1M 0.01% 724
2021
Q4
$13.1M Buy
102,985
+23,686
+30% +$3.11M 0.06% 277
2021
Q3
$10.3M Buy
79,299
+11,032
+16% +$1.67M 0.06% 319
2021
Q2
$12.1M Buy
68,267
+5,334
+8% +$924K 0.07% 268
2021
Q1
$10.3M Sell
62,933
-10,115
-14% -$1.66M 0.06% 296
2020
Q4
$12.1M Sell
73,048
-26,205
-26% -$3.9M 0.07% 258
2020
Q3
$14.2M Sell
99,253
-18,194
-15% -$2.26M 0.1% 186
2020
Q2
$13M Sell
117,447
-11,654
-9% -$1.29M 0.11% 178
2020
Q1
$12.9M Buy
129,101
+9,971
+8% +$1.29M 0.12% 169
2019
Q4
$17.8M Sell
119,130
-78,469
-40% -$10.7M 0.14% 166
2019
Q3
$25.3M Buy
197,599
+67,060
+51% +$8.99M 0.21% 93
2019
Q2
$18.6M Buy
130,539
+19,109
+17% +$2.57M 0.16% 132
2019
Q1
$15.9M Buy
111,430
+15,821
+17% +$2.06M 0.14% 158
2018
Q4
$11.9M Buy
95,609
+465
+0.5% +$69K 0.12% 196
2018
Q3
$16M Sell
95,144
-59,711
-39% -$10.3M 0.14% 173
2018
Q2
$26.7M Sell
154,855
-20,311
-12% -$3.32M 0.24% 88
2018
Q1
$26.4M Buy
175,166
+9,689
+6% +$1.42M 0.24% 87
2017
Q4
$22.3M Sell
165,477
-10,118
-6% -$1.4M 0.2% 111
2017
Q3
$25.7M Sell
175,595
-11,642
-6% -$1.76M 0.24% 95
2017
Q2
$29.1M Buy
187,237
+173,825
+1,296% +$26.6M 0.29% 74
2017
Q1
$1.95M Buy
13,412
+499
+4% +$65K 0.02% 643
2016
Q4
$1.41M Sell
12,913
-6,356
-33% -$708K 0.01% 707
2016
Q3
$2.34M Sell
19,269
-1,479
-7% -$199K 0.02% 578
2016
Q2
$2.93M Sell
20,748
-26,563
-56% -$3.92M 0.04% 443
2016
Q1
$6.18M Sell
47,311
-600
-1% -$74.7K 0.08% 269
2015
Q4
$6.73M Sell
47,911
-135,365
-74% -$18.8M 0.09% 231
2015
Q3
$24.3M Sell
183,276
-6,183
-3% -$1.06M 0.34% 68
2015
Q2
$33.4M Sell
189,459
-9,727
-5% -$1.75M 0.46% 52
2015
Q1
$34.4M Buy
199,186
+195,273
+4,990% +$33.5M 0.48% 52
2014
Q4
$641K Buy
+3,913
New +$649K 0.02% 640
2014
Q3
Sell
-70,000
Closed -$10.3M 979
2014
Q2
$10.3M Buy
70,000
+53,000
+312% +$7.35M 0.3% 71
2014
Q1
$2.36M Hold
17,000
0.07% 313
2013
Q4
$2.15M Hold
17,000
0.07% 310
2013
Q3
$1.56M Hold
17,000
0.05% 359
2013
Q2
$1.17M Buy
+17,000
New +$1.04M 0.04% 396

Other funds holding JAZZ

Zurich Cantonal Bank's JAZZ Position: Q1 2026 in Review

Zurich Cantonal Bank increased its Jazz Pharmaceuticals (JAZZ) stake by 60% in Q1 2026, buying an estimated $23.9M and bringing the position to 365,451 shares worth $69.1M. The position accounts for 0.15% of the portfolio, ranked #121.

Zurich Cantonal Bank first reported a position in JAZZ in Q2 2013 and has held it in 51 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Zurich Cantonal Bank held 365,451 shares of Jazz Pharmaceuticals worth $69.1M as of Q1 2026.
  • Zurich Cantonal Bank bought 136,809 Jazz Pharmaceuticals shares in Q1 2026, an estimated $23.9M.
  • Jazz Pharmaceuticals made up 0.15% of Zurich Cantonal Bank's portfolio in Q1 2026, its #121 holding.
  • Zurich Cantonal Bank first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.